Reference : Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview o...
Scientific journals : Article
Human health sciences : Rheumatology
http://hdl.handle.net/2268/126172
Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives.
English
Henrotin, Yves mailto [Université de Liège - ULg > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.) >]
2012
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society
20
3
215-7
Yes (verified by ORBi)
International
1522-9653
England
[en] Biological Markers/metabolism ; Biomedical Research/methods ; Humans ; Osteoarthritis/diagnosis/metabolism ; Proteome/analysis
[en] The "year in review" session is a key moment of the Osteoarthritis Research Society International (OARSI) Congress. This is a unique opportunity for opinion leaders to summarize and comment the recent advances in one particular field of osteoarthritis research. This review is a summary of selected studies related to soluble biomarkers published between September 1st, 2010 and August 30th, 2011 and identified by a pubmed search using the terms "biomarkers" and "osteoarthritis". In addition, I have selected some works presented during the 2011 OARSI Congress. This year was dominated by the publication of a consensus paper on the qualification of osteoarthritis (OA) biomarkers by the OARSI/Food Drug Administration (FDA) Osteoarthritis Biomarkers Working Group, and of proteomes of chondrocyte vesicles, urine and serum.
http://hdl.handle.net/2268/126172
Copyright A(c) 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. Level +5, CHU Sart-Tilman, 4000 Liege, Belgium. yhenrotin@ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Biomarker 2011 review YJOCA2566.pdfPublisher postprint303.9 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.